Search

everythinglearnresearchcommunity

for

Search:↓

High levels of 3 alpha-diol glucuronide in the blood are a marker of increased androgen action in women with excessive hair growth of unknown cause.

Certain hormone treatments can increase SBP levels and help with mild body hair growth.

Taking spironolactone and linestrenol for androgen excess can lead to lower bone density in young women.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Cyproterone acetate is a safe treatment that causes mild feminizing effects in adolescent trans-girls.

Oral contraceptives help mild hirsutism, while flutamide and spironolactone help severe cases.

A postmenopausal woman's excessive hair growth and hair loss were due to a non-cancerous ovarian condition, treated successfully with surgery.

Cyproterone acetate implants were more effective at reducing facial hair and improving skin in severe hirsutism than oral treatment.

All treatments reduce hair growth; low dose flutamide most effective with fewer side effects.

Topical finasteride may help treat facial hirsutism in women.

Diane and Androcur 10 improved acne and seborrhea in most women, and hirsutism and alopecia in about half.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Dienogest combined with ethinylestradiol is a highly effective birth control that improves menstrual symptoms and has manageable side effects.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Testosterone therapy can help postmenopausal women with low sexual desire if monitored carefully.

Estrogens and progesterones can help manage various health issues.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Spironolactone most effective for hirsutism, but has side effects.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

Finasteride reduces hair growth in women with hirsutism and works better with electrolysis.

Cyproterone acetate is an effective treatment for women with acne, hair loss, and excessive hair growth.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

Antiandrogens are somewhat effective in reducing excessive hair growth in women.

Flutamide is more effective and has fewer side effects than spironolactone for treating hirsutism.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.